Abbot Financial Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,907
Closed -$869K 134
2025
Q3
$869K Sell
12,907
-220
-2% -$17.4K 0.37% 68
2025
Q2
$1.15M Buy
13,127
+1,284
+11% +$101K 0.53% 54
2025
Q1
$809K Buy
11,843
+40
+0.3% +$3.26K 0.42% 67
2024
Q4
$918K Sell
11,803
-20
-0.2% -$1.48K 0.46% 58
2024
Q3
$793K Buy
11,823
+4,374
+59% +$359K 0.4% 68
2024
Q2
$845K Buy
7,449
+455
+7% +$57.5K 0.45% 59
2024
Q1
$970K Buy
6,994
+337
+5% +$42.4K 0.54% 51
2023
Q4
$826K Buy
6,657
+1,560
+31% +$159K 0.5% 60
2023
Q3
$476K Buy
5,097
+1,177
+30% +$133K 0.32% 81
2023
Q2
$504K Sell
3,920
-193
-5% -$23.3K 0.32% 79
2023
Q1
$478K Hold
4,113
0.32% 79
2022
Q4
$466K Buy
4,113
+25
+0.6% +$2.75K 0.32% 78
2022
Q3
$329K Hold
4,088
0.23% 89
2022
Q2
$305K Buy
4,088
+396
+11% +$36.1K 0.18% 100
2022
Q1
$472K Buy
3,692
+344
+10% +$37.6K 0.23% 90
2021
Q4
$449K Buy
3,348
+52
+2% +$7.47K 0.2% 92
2021
Q3
$451K Sell
3,296
-1,144
-26% -$144K 0.21% 92
2021
Q2
$474K Buy
4,440
+288
+7% +$27.7K 0.21% 88
2021
Q1
$373K Buy
4,152
+336
+9% +$31.5K 0.17% 94
2020
Q4
$353K Buy
+3,816
New +$341K 0.2% 91

Other funds holding DXCM

Abbot Financial Management's DXCM Position: Q4 2025 in Review

Abbot Financial Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 12,907 shares — an estimated $869K sold.

Abbot Financial Management first reported a position in DXCM in Q4 2020 and held it in 20 quarters. The position peaked at $1.15M in Q2 2025. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Abbot Financial Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Abbot Financial Management sold 12,907 DexCom shares in Q4 2025, an estimated $869K.
  • Abbot Financial Management first reported a position in DexCom in Q4 2020 and held it in 20 quarters.
  • Abbot Financial Management's DexCom position peaked at $1.15M in Q2 2025.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Abbot Financial Management's 13F filing for Q4 2025, filed 13 Feb 2026.